The Role of Paraprobiotics in Breast Cancer Cell Line (MCF-7): In vitro study

  • Gulcin Alp Avci University of Health Sciences Faculty of Gulhane Dentistry
  • Emre Avci Department of Biochemistry, Faculty of Gulhane Pharmacy, University of Health Sciences, Ankara, Turkiye

Abstract

Bioactive active metabolites seem promising in understanding the molecular pathology of cancer and especially in developing targeted therapies. In addition, the anticancer activity of some possible probiotic bacteria is emphasized in many literatures. Especially Lactobacillus strains and beneficial microbial activities are noteworthy. However, the use of live microorganisms in immunocompromised patients poses a risk. For this reason, our study aimed to evaluate the cytotoxic effect of inanimate/paraprobiotics obtained from probiotic microorganisms on the MCF-7 cell line, which is a breast cancer cell. L. rhamnosus ATCC 53103 and L. reuteri DSM 17938 strains and the MCF-7 cell line were used in our study. The cytotoxicity of paraprobiotics was determined by the MTT method. According to the obtained data, it was observed that paraprobiotics had a concentration and time dependent proliferative effect on healthy fibroblast cell lines and a cytotoxic effect dependent on the same parameters on MCF-7 cell lines. While the search for new pharmabiotic active molecules continues today, the identification of bioactive paraprobiotics will enable their use especially in individuals with immune system diseases and will allow the shelf life of biotic products to be longer.

Keywords: Paraprobiotics, Bioactive substances, breast cancer, MCF-7

Downloads

Download data is not yet available.

References

1. Hammer GP, Seidenbusch MC, Schneider K, Regulla D, Zeeb H, Spix C et al. (2010). Cancer incidence rate after diagnostic X-ray exposure in 1976–2003 among patients of a university children’s hospital [in German]. Rofo [Internet]. 2010 [cited 2024 Nov 10]; 182(5):404-14. Available from:
doi:10.1055/s-0029-1245235.
2. Zhu H, Doğan BE. American Joint Committee on Cancer's Staging System for Breast Cancer, Eighth Edition: Summary for Clinicians. Eur J Breast Health [Internet]. 2021 Jun 24 [cited 2024 Nov 10]; 17(3):234-238. Available from:
doi: 10.4274/ejbh.galenos.2021.2021-4-3.
3. Stec J, Kosikowska U, Mendrycka M, Stępień-Pyśniak D, Niedźwiedzka-Rystwej P, Bębnowska D, Hrynkiewicz R, Ziętara-Wysocka J, Grywalska E. Opportunistic Pathogens of Recreational Waters with Emphasis on Antimicrobial Resistance-A Possible Subject of Human Health Concern. Int J Environ Res Public Health [Internet]. 2022 Jun 14 [cited 2024 Nov 10]; 19(12):7308. Available from:
doi: 10.3390/ijerph19127308.
4. Mudaliar, S.B., Poojary, S.S., Bharath Prasad, A.S. et al. Probiotics and Paraprobiotics: Effects on Microbiota-Gut-Brain Axis and Their Consequent Potential in Neuropsychiatric Therapy. Probiotics & Antimicro. Prot.16 [Internet]. 2024 [cited 2024 Nov 10]. p. 1440-1464. Available from:
doi.org/10.1007/s12602-024-10214-6.
5. Ali MS, Lee EB, Hsu WH, Suk K, Sayem SAJ, Ullah HMA, Lee SJ, Park SC. Probiotics and Postbiotics as an Alternative to Antibiotics: An Emphasis on Pigs. Pathogens [Internet]. 2023 Jun 26 [cited 2024 Nov 12]; 12(7):874. Available from:
doi: 10.3390/pathogens12070874.
6. Garg V, Velumani D, Lin Y-C, Haye A. A comprehensive review of probiotic claims regulations: Updates from Asia-Pacific, United States, and Europe. PharmaNutrition [Internet]. 2024 [cited 2024 Nov 12]; 30:100423. Available from:
doi: 10.1016/j.phanu.2024.100423.
7. Siciliano RA, Reale A, Mazzeo MF, Morandi S, Silvetti T, Brasca M. Paraprobiotics: A New Perspective for Functional Foods and Nutraceuticals. Nutrients [Internet]. 2021 Apr 8 [cited 2024 Nov 12]; 13(4):1225. Available from:
doi: 10.3390/nu13041225.
8. G.A. Avci, U.I. Yilmaz, E. Avci, Efficacy of probiotics, paraprobiotics, and postbiotics in colorectal cancer cell line and their role in immune response. Rev Assoc Med Bras (1992) [Internet]. 2024 [cited 2024 Nov 12]; 70(6), e20240226. Available from:
doi: 10.1590/1806-9282.20240226.
9. Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, Vignat J, Gralow JR, Cardoso F, Siesling S, Soerjomataram I. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast [Internet]. 2022 Dec [cited 2024 Nov 12]; 66:15-23. Available from:
doi: 10.1016/j.breast.2022.08.010.
10. Śliżewska K, Markowiak-Kopeć P, Śliżewska W. The Role of Probiotics in Cancer Prevention. Cancers (Basel). [Internet]. 2020 Dec 23 [cited 2024 Nov 12]; 13(1):20. Available from:
doi: 10.3390/cancers13010020
11. Goldin, B.R.; Gorbach, S.L. Effect of Lactobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine dihydrochlorideinduced intestinal cancer in rats. J. Natl. Cancer Inst. [Internet]. 1980 [cited 2024 Nov 12]; 64, 263-265. Available from:
doi: 10.1093/jnci/64.2.263.
12. Wang Z, Li L, Wang S, Wei J, Qu L, Pan L, Xu K. The role of the gut microbiota and probiotics associated with microbial metabolisms in cancer prevention and therapy. Front Pharmacol. [Internet]. 2022 Nov 14 [cited 2024 Nov 13]; 13:1025860. Available from:
doi: 10.3389/fphar.2022.1025860.
13. Hammad N, Hammad HUI, Muhammad S. et. al., Role of Probiotics against Human Cancers, Inflammatory Diseases, and Other Complex Malignancies, Journal of Food Biochemistry [Internet]. 2024 [cited 2024 Nov 13]; 6632209:23. Available from:
doi: 10.1155/2024/6632209.
14. Deng X, Yang J, Zhang Y, Chen X, Wang C, Suo H, Song J. An Update on the Pivotal Roles of Probiotics, Their Components, and Metabolites in Preventing Colon Cancer. Foods. [Internet]. 2023 [cited 2024 Nov 13]; 12(19):3706. Available from:
doi: 10.3390/foods12193706
Statistics
351 Views | 0 Downloads
How to Cite
1.
Alp Avci G, Avci E. The Role of Paraprobiotics in Breast Cancer Cell Line (MCF-7): In vitro study. Int J Drug Reg Affairs [Internet]. 2024Dec.15 [cited 2026Apr.23];12(4):103-6. Available from: https://www.ijdra.com/index.php/journal/article/view/728